The UK government has launched a comprehensive overhaul of its rules surrounding National Health Service (NHS) inventions, aiming to unlock billions for the economy by expediting the development and commercialisation of homegrown medical innovations.
This is the first significant update in 23 years, replacing a framework that officials admit was designed for a pre-digital era and was ill-equipped to handle modern advancements, particularly in areas like artificial intelligence. At its core, the new policy governs the management of intellectual property (IP)—the process of protecting and commercialising new ideas developed by NHS staff using public resources, including diagnostic software and medical devices.
